PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-101.75%
Negative net income growth while CX stands at 232.13%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-48.94%
Negative yoy D&A while CX is 10.26%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
30.17%
SBC growth while CX is negative at -100.00%. John Neff would see competitor possibly controlling share issuance more tightly.
-455.12%
Both reduce yoy usage, with CX at -235.91%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth while CX is negative at -177.91%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
66.87%
Inventory growth well above CX's 56.49%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce yoy usage, with CX at -201.70%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-76.09%
Negative yoy while CX is 59.98%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-121.11%
Both yoy CFO lines are negative, with CX at -102.45%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
64.19%
CapEx growth well above CX's 40.32%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
93.40%
Acquisition spending well above CX's 9.82%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
93.55%
Some yoy expansion while CX is negative at -100.00%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
No Data
No Data available this quarter, please select a different quarter.
-107.30%
Both yoy lines negative, with CX at -99.52%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
83.83%
We have mild expansions while CX is negative at -17.39%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
118.93%
We repay more while CX is negative at -162.09%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-80.00%
Negative yoy issuance while CX is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
54.78%
Buyback growth at 50-75% of CX's 100.00%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.